Syngene International Ltd Share Price (SYNGENE)
₹694
Syngene International Ltd share Performance
- ₹690.45₹711.3₹694
0.51%
Low
Day's Volatility:3.00%
High
2.49%
- ₹611.2₹860.25₹694
11.93%
Low
52 Weeks Volatility:35.89%
High
23.96%
| Returns % | |
| 1 Month Return | -0.58 % |
| 3 Month Return | 0.78 % |
| 1 Year Return | 13.05 % |
| Market Stats | |
| Previous Close | ₹701.05 |
| Open | ₹704.75 |
| Volume | 9.49L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹28,183.26Cr |
Analyst Rating for Syngene International Ltd stock
based on 8 analysts
Based on 8 analysts offering long term price targets for Syngene International Ltd. An average target of ₹761.38
Source: S&P Global Market Intelligence
Company Information
Share Price: ₹694.00 per share as on 24 Apr, 2024 04:01 PM
Market Capitalisation: ₹28,183.26Cr as of today
Revenue: ₹853.50Cr as on December 2023 (Q4 23)
Net Profit: ₹111.50Cr as on December 2023 (Q4 23)
Listing date: 11 Aug, 2015
Chairperson Name: Kiran Mazumdar Shaw
| Organisation | Syngene International Ltd |
| Headquarters | |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for Syngene International Ltd
Syngene International Reports Q4 Results - 24 Apr, 2024
Syngene International reported a net profit of Rs. 188.6 crore in Q4FY24, up 5% YoY, with revenue falling 8% YoY to Rs. 916.9 crore. The company's board recommended a final dividend of Rs. 1.25 per share for FY24, an increase of 150% over last year.
Goldman Sachs Initiates Buy Rating on Syngene International - 12 Apr, 2024
Goldman Sachs has initiated coverage on Syngene International Ltd with a buy rating and raised the target price by 20%. The company's stock witnessed a surge in volume and increased by 3.69% to Rs. 759.10.
Syngene Receives Tax Demand, Reports Q3 Results - 30 Mar, 2024
Syngene International received a tax demand of Rs 16 crore from the Income Tax Department for assessment year 2022-23 and is analyzing the order. The company reported a 2% rise in consolidated net profit to Rs 112 crore and an 8.65% increase in revenue from operations to Rs 854 crore in Q3 FY24 over Q3 FY23. Shares fell 1.41%.
Syngene International's Debt Load Eases with 20% EBIT Growth - 28 Mar, 2024
Syngene International had a net cash position of Rs. 5.78 billion, making its debt load easier to handle. The company grew its EBIT by 20% last year and recorded free cash flow worth 51% of its EBIT over the past three years. Overall, Syngene International's use of debt is not considered risky.
Fundamentals of Syngene International Ltd
Insights on Syngene International Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTMF Holding Up
Mutual Funds have increased holdings from 11.93% to 12.59% in Mar 2024 quarter
- POSITIVE IMPACT
Price Rise
In the last 3 years, SYNGENE stock has moved up by 17.1%
NO EFFECTAgainst Peers
In the last 1 year, Shree Ganesh Remedies Ltd has given 105.6% return, outperforming this stock by 92.6%
- NO EFFECT
Against Peers
In the last 3 years, Shree Ganesh Remedies Ltd has given 159.0% return, outperforming this stock by 141.9%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 54.79% of holdings in Mar 2024 quarter
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 2 quarters, 116.5 Cr → 111.5 Cr (in ₹), with an average decrease of 4.3% per quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 9.05% to 8.17% in Mar 2024 quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 931.7 Cr → 882.8 Cr (in ₹), with an average decrease of 5.3% per quarter
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 21.20% to 20.92% in Mar 2024 quarter
Syngene International Ltd Valuation
Syngene International Ltd in the last 5 years
Lowest (23.09x)
March 31, 2020
Today (56.67x)
April 23, 2024
Industry (61.41x)
April 23, 2024
Highest (70.41x)
September 7, 2023
Mutual Fund Holdings
| Funds | Holdings |
 Mirae Asset Focused Fund Direct Growth | 3.25% |
 ICICI Prudential ELSS Tax Saver Fund Direct Plan Growth | 1.83% |
| ICICI Prudential Multicap Fund Direct Plan Growth | 1.98% |
| ICICI Prudential Large & Mid Cap Fund Direct Plan Growth | 1.62% |
 UTI Flexi Cap Fund - Growth Option - Direct | 0.81% |
Shareholding Pattern
| Investors | Holdings % | Prev. 1 periods | 3M change |
|---|---|---|---|
| Promoter Holdings | 54.79% | 0.00 | |
| Foreign Institutions | 20.92% | 0.00 | |
| Mutual Funds | 12.59% | 0.00 | |
| Retail Investors | 8.17% | 0.00 | |
| Others | 3.52% | 0.00 |
Technicals of Syngene International Ltd share
News & Events of Syngene International Ltd
Frequently Asked Questions
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Syngene International Ltd shares.
Syngene International Ltd (SYNGENE) share price today is ₹694
Syngene International Ltd is listed on NSE
Syngene International Ltd is listed on BSE
- Today’s highest price of Syngene International Ltd is ₹711.3.
- Today’s lowest price of Syngene International Ltd is ₹690.45.
PE Ratio of Syngene International Ltd is 56.67
PE ratio = Syngene International Ltd Market price per share / Syngene International Ltd Earnings per share
Today’s traded volume of Syngene International Ltd(SYNGENE) is 9.49L.
Today’s market capitalisation of Syngene International Ltd(SYNGENE) is ₹28183.26Cr.
| Syngene International Ltd(SYNGENE | Price |
|---|---|
52 Week High | ₹860.25 |
52 Week Low | ₹611.2 |
Syngene International Ltd(SYNGENE) share price is ₹694. It is down -19.33% from its 52 Week High price of ₹860.25
Syngene International Ltd(SYNGENE) share price is ₹694. It is up 13.55% from its 52 Week Low price of ₹611.2
| Syngene International Ltd(SYNGENE | Returns |
|---|---|
1 Day Returns | -7.05% |
1 Month Returns | -0.58% |
3 Month Returns | 0.78% |
1 Year Returns | 13.05% |